Pharmaceutical Analysis & Statistics, December 2014

You might be interested in: Therapeutics, Drug, Cancer, more »

1-30 of about 100 reports

Purchase Reports From Reputable Market Research Publishers

Peptide Therapeutics Database

Peptide Therapeutics Database

  • $ 1 056
  • Industry report
  • November 2014
  • by La Merie Publishing

Peptide Therapeutics Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on ...

  • Industries : Therapy
Competitor Analysis: Cancer Peptides

Competitor Analysis: Cancer Peptides

  • $ 528
  • Industry report
  • November 2014
  • by La Merie Publishing

Competitor Analysis: Cancer Peptides The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide ...

  • Industries : Pathology
Competitor Analysis: Cardiometabolic Peptides

Competitor Analysis: Cardiometabolic Peptides

  • $ 528
  • Industry report
  • November 2014
  • by La Merie Publishing

Competitor Analysis: Cardiometabolic Peptides The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in the development pipeline of peptide ...

  • Industries : Pathology
Competitor Analysis: Anti-Infective Peptides

Competitor Analysis: Anti-Infective Peptides

  • $ 462
  • Industry report
  • October 2014
  • by La Merie Publishing

Competitor Analysis: Anti-Infective Peptides The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation ...

  • Industries : Drug and Medication
Competitor Analysis: Cardiovascular Peptides

Competitor Analysis: Cardiovascular Peptides

  • $ 396
  • Industry report
  • October 2014
  • by La Merie Publishing

Competitor Analysis: Cardiovascular Peptides The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, ...

  • Industries : Pathology
Competitor Analysis: Anti-Inflammatory Peptides

Competitor Analysis: Anti-Inflammatory Peptides

  • $ 330
  • Industry report
  • September 2014
  • by La Merie Publishing

Competitor Analysis: Anti-Inflammatory Peptides The present Competitive Intelligence Report about peptides therapeutics provides a competitor evaluation in the field of marketed and new molecules fo ...

  • Industries : Drug and Medication
Competitor Analysis: Ebola Virus Vaccines and Therapeutics

Competitor Analysis: Ebola Virus Vaccines and Therapeutics

  • $ 264
  • Industry report
  • October 2014
  • by La Merie Publishing

Competitor Analysis: Ebola Virus Vaccines and Therapeutics The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections provides a competitor evaluation in the ...

  • Industries : Therapy
Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

  • $ 462
  • Industry report
  • August 2014
  • by La Merie Publishing

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists The Competitive Intelligence Report Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists as of August 2014 provides a competitor analysis in the development ...

  • Industries : Pathology
Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

  • $ 264
  • Industry report
  • July 2014
  • by La Merie Publishing

Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors The present Competitive Intelligence Report about alpha1-proteinase inhibitors (alpha1-PI), ...

  • Industries : Pathology
Competitor Analysis: Phosphodiesterase 4 (PDE-4) Inhibitors

Competitor Analysis: Phosphodiesterase 4 (PDE-4) Inhibitors

  • $ 264
  • Industry report
  • June 2014
  • by La Merie Publishing

The present Competitive Intelligence Report about phosphodiesterease 4 (PDE-4) Inhibitors provides a competitor evaluation in the field of mainly small molecules specifically or unspecifically inhibiting ...

  • Industries : Pathology
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics

Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics

  • $ 264
  • Industry report
  • January 2014
  • by La Merie Publishing

Novel Prophylactic and Therapeutic Approaches to Manage and Prevent Clostridium difficile Infections (CDI) Clostridium difficile infections (CDI) are a major public health concern.  CDI are becoming ...

  • Industries : Drug and Medication
Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors

Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors

  • $ 528
  • Industry report
  • November 2013
  • by La Merie Publishing

Develpment update for new JAK and syk Inhibitors This Competitive Intelligence Report about new developments in the pipeline of inhibitors of the janus-associated kinase (JAK) and of spleen tyrosine ...

  • Industries : Pathology
Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives)

Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives)

  • $ 660
  • Industry report
  • October 2013
  • by La Merie Publishing

Novel Prophylactic and Therapeutic Approaches to Manage Staphylococcus aureus (S. aureus) Infections Staphylococcus aureus disease is the leading cause of surgical site infections and infections that ...

  • Industries : Drug and Medication
Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors

Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors

  • $ 264
  • Industry report
  • October 2013
  • by La Merie Publishing

Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors Product description Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid ...

  • Industries : Drug Delivery Technology
Competitor Analysis: Pim Kinase Inhibitors

Competitor Analysis: Pim Kinase Inhibitors

  • $ 132
  • Industry report
  • September 2013
  • by La Merie Publishing

Competitor Analysis: Pim Kinase Inhibitors Product description The three Pim kinases are a small family of serine/threonine kinases regulating several signaling pathways that are fundamental to cance ...

  • Industries : Therapy
Competitor Analysis: Bruton's Tyrosine Kinase (BTK) Inhibitors

Competitor Analysis: Bruton's Tyrosine Kinase (BTK) Inhibitors

  • $ 132
  • Industry report
  • August 2013
  • by La Merie Publishing

Competitor Analysis: Bruton Tyrosine Kinase (BTK) Inhibitors Product description The present Competitive Intelligence report about Bruton's Tyrosine Kinase (BTK) Inhibitors provides a competito ...

  • Industries : Pathology
Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

  • $ 198
  • Industry report
  • August 2013
  • by La Merie Publishing

Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors Product description The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competito ...

  • Industries : Pathology
Competitor Analysis: Smallpox Vaccines & Therapeutics

Competitor Analysis: Smallpox Vaccines & Therapeutics

  • $ 198
  • Industry report
  • August 2013
  • by La Merie Publishing

Competitor Analysis: Smallpox Vaccines & Therapeutics Product description The Competitive Intelligence report Smallpox Vaccines & Therapeutics as of August 2013 provides a competitor analysis in ...

  • Industries : Drug and Medication
Competitor Analysis: Anthrax Vaccines & Therapeutics

Competitor Analysis: Anthrax Vaccines & Therapeutics

  • $ 264
  • Industry report
  • June 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Anthrax Vaccines & Therapeutics as of June 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics fo ...

  • Industries : Drug and Medication
Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

  • $ 330
  • Industry report
  • May 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Human Papilloma Virus (HPV) Vaccines & Therapeutics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines ...

  • Industries : Drug and Medication
Competitor Analysis: Interferon

Competitor Analysis: Interferon

  • $ 594
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Interferon as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant and natural interferon ...

  • Industries : Drug and Medication
Competitor Analysis: Insulin

Competitor Analysis: Insulin

  • $ 594
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Insulin as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant insulin and insulin ...

  • Industries : Pathology
  • Countries : India, China
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

  • $ 330
  • Industry report
  • February 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development ...

  • Industries : Therapy
Competitor Analysis: Herpes Virus Vaccines and Therapeutics

Competitor Analysis: Herpes Virus Vaccines and Therapeutics

  • $ 396
  • Industry report
  • December 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Herpes Virus Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies ...

  • Industries : Drug and Medication
Competitor Analysis: Pneumococcal and Streptococcal Vaccines

Competitor Analysis: Pneumococcal and Streptococcal Vaccines

  • $ 264
  • Industry report
  • October 2012
  • by La Merie Publishing

The present Competitive Intelligence Report about Pneumococcla and Streptococcal Vaccines provides a competitor evaluation in the field of prophylactic vaccines against infection caused by streptococcus ...

  • Industries : Drug and Medication
Competitor Analysis: Tuberculosis Vaccines and Therapeutics

Competitor Analysis: Tuberculosis Vaccines and Therapeutics

  • $ 528
  • Industry report
  • September 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Tuberculosis Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic small molecules ...

  • Industries : Drug and Medication
Competitor Analysis: CMV Vaccines & Therapeutics

Competitor Analysis: CMV Vaccines & Therapeutics

  • $ 264
  • Industry report
  • August 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about CMV Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, antisense, ...

  • Industries : Drug and Medication
Competitor Analysis: Malaria Vaccines & Therapeutics

Competitor Analysis: Malaria Vaccines & Therapeutics

  • $ 396
  • Industry report
  • August 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Malaria Vaccines & Therapeutics provides a competitor evaluation in the field of investigational small molecules and biologics to treat ...

  • Industries : Drug and Medication
Competitor Analysis: Dengue Virus Vaccines and Therapeutics

Competitor Analysis: Dengue Virus Vaccines and Therapeutics

  • $ 264
  • Industry report
  • July 2012
  • by La Merie Publishing

The present Competitive Intelligence Report about Dengue Virus Vaccines & Therapeutics provides a competitor evaluation in the field of investigational vaccines and therapeutics against one or more serotypes ...

  • Industries : Drug and Medication
Competitor Analysis: RSV Vaccines and Therapeutics

Competitor Analysis: RSV Vaccines and Therapeutics

  • $ 330
  • Industry report
  • June 2012
  • by La Merie Publishing

Competitor Analysis: Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics The present Competitive Intelligence Report about RSV Vaccines & Therapeutics provides a competitor evaluation in the ...

  • Industries : Drug and Medication
  • Countries : United States

1 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.